Tenant Listing
Alphabetical
- AmpliPhi
- Bill Police, LLC
Assists businesses in managing their cell phone bills more cost effectively by simplifying the bill into one easy-to-read format, identifying and correcting billing errors with the carrier, suggesting more cost-effective alternatives and providing historical trend analysis. Its proprietary software application is web-enabled and will serve not only cell phone users but also future applications involving wireless data and wireless applications. Possible examples include wireless timecards or global positioning. Bill Police's target market is businesses with 10 or more mobile phones. Typical monthly cost savings average 25 percent. Additional cost savings of time and manpower also are significant. The price is $5 or $7 per subscriber per month.
Kae K. Zulager, CEO
Phone: (804) 640-3334
Email: kae@billpolice.comRonald V. Carpenter, Senior VP
Phone: (804) 640-3332
Email: ron@billpolice.comClifton L. Rogers, branch operations manager
Phone: (804) 422-1560
Email: cliff@billpolice.comDaren Carpenter, Director of IT
Email: daren@billpolice.com - Bio Cancell Therapeutics, Inc.
BioCancell Therapeutics, Inc., a biopharmaceuticals corporation, has developed patient-oriented, and therefore patient-specific, targeted therapy for the treatment of numerous types of cancer. The treatment is based on utilizing the H-19 gene — an important oncofetal gene — expressed at high levels in more than 30 types of human cancer tissues, while existing at a nearly undetectable level in the surrounding normal tissues. BioCancell Therapeutics was founded in 2004 by Professor Abraham Hochberg, professor of molecular biology at the Hebrew University of Jerusalem. BioCancell's R&D activities are conducted through its wholly owned Israel-based subsidiary,
BioCancell Therapeutics, Ltd.
Donna Edmonds
Phone: (804) 212-2975
Fax: (804) 828-8566
Email: dedmonds@vbcc-inc.com - BioProtect
BioProtect has developed an innovative medical device platform consisting of a biodegradable, inflatable balloon that can be implanted into the body with a quick, minimally invasive process. The device can be used to enhance prostate cancer treatment by moving healthy tissue from the radiation pathway. This technology leads to decreased side effects and allows for increased radiation intensity and fewer overall treatment sessions. The device can also be used in the orthopedic market to assist with successful repair of rotator cuff tears.
Kate Webster
Phone: (804) 212-2299
Fax: (804) 828-8566
Email: kwebster@vbcc-inc.com - BluePrint Genomics, Inc.
BPG focuses on development and application of high-throughput genomic technologies in the area of personalized medicine.
Gregory A. Buck, Ph.D.
Phone: (804) 852-4137
Email: blueprintgenomicsinc@gmail.com - Castle Technologies
Develops and implements enterprise-wide health informatics applications, with proven expertise in areas such as case management, disease management and utilization management. Founded in 1994 in Richmond, Va., Castle is an 8(a)- and MBE/DBE-certified company that has provided I.T. solutions for managed care, state Medicaid/Medicare, for-profit and nonprofit organizations.
http://www.castletechnologies.com
Justin Samson, president
Phone: (804) 747-3761
Fax: (804) 747-3636
Email: info@castletechnologies.com - Center for Research & Technology
Biotech Nine is home to the Center for Research and Technology. Opened in late 2007, this complex is bounded by 5th and 7th streets just north of the Richmond Coliseum. The Center encompasses a total of 450,000 square feet and employs approximately 600 scientists, engineers and support staff. The Center is designed to promote collaboration and creativity and to develop technologies that improve Altria Group's operating companies' current products and lead to innovative new products.
- Center for Transplant System Excellence
The Center for Transplant System Excellence is a UNOS initiative to conduct collaborative research and education to advance the field of organ transplantation.
The center provides the leadership and resources needed to coordinate on-going multi-disciplinary collaboration in evidence-based research and clinical practice improvements. - CreativeAid
- Creswell Partners
Creswell Partners enables small business owners to accelerate the growth and value of their companies. We partner with owners and entrepreneurs who desire near-term liquidity, a clear path for their transition, and to achieve greater scale in advance of an eventual exit. We work as operators alongside the existing team to implement the initiatives necessary to build scale and strengthen the strategic position of the enterprise, while also enabling the current owner to reduce the time they spend on day-to-day operations and diversify their investments. We have experience with a number of industries, including business services, consumer products, healthcare services, medical devices, technology, industrial manufacturing and services, and energy products and services.
Website: www.creswellpartners.com
Jeffrey Herr, CFA
+1-804-402-2951
jeff@creswellpartners.comJason Herzog
+1-804-955-5246
jason@creswellpartners.comDavid Keys, CFA
+1-804-400-4909
dkeys@creswellpartners.com - Cupron, Inc.
Cupron has developed a unique and efficient platform technology that promises to dramatically improve public health and prevent the spread of disease. Utilizing the unique qualities of copper, Cupron's patented technology adds a broad-spectrum antimicrobial (antibacterial, antiviral, antifungal and anti-mite) compound to a wide range of products through use of nontoxic chemical processes. Emerging data is very compelling in embedded products and in wound care.
John D. Cudzik
Phone: (804) 780-0069
Fax: (804) 828-8566
Email: jdcudzik@cupronmedical.com - Donate Life
- eHealthObjects
- EnzySurge Ltd.
EnzySurge Ltd. is a developer and provider of innovative solutions for the treatment and management of chronic wounds. EnzySurge's patented and FDA-cleared DermaStream™ - an innovative wound care platform, which together with a set of advanced bio-active solutions, forms the basis for the new and unique wound treatment modality - Continuous Streaming Therapy™. CST enables a new, controlled chronic wound environment that ensures a continuous fresh supply of therapeutic solutions to the wound. DermaStream is designed to deliver effective, affordable and easy-to-use wound treatment throughout all phases of chronic wound lifecycle, including selective wound debridement (removal of necrotic tissue), bacterial load reduction and enhanced healing. DermaStream was designed for use in hospitals, clinics and home care. EnzySurge is committed to the development and delivery of innovative solutions that improve the quality of life of chronic-wound patients, by shortening healing time and reducing treatment costs. For more information, visit www.dermastream.com.
Nicole Colomb
Phone: (804) 212-2974
Fax: (804) 828-8566
Email: ncolomb@vbcc-inc.com - Fanevil Medical Ltd.
Paul Rocheleau
(804) 780-0031
procheleau@vlsillc.com - Gardia Medical
Gardia Medical specializes in the development of catheter-based delivery systems that easily integrate with the standard workflow of stenting and other cardiovascular intervention procedures. Their proprietary Deliver, Lock and Deploy (DLD) technology consists of an advanced mechanical locking mechanism and stand-alone filter that are delivered via a delivery catheter, and can be positioned in any location along the vessel without compromising guidewire performance. Its modular approach provides a unique and elegant solution in cardiovascular intervention. Gardia is currently introducing the first wire-independent distal filtration Embolic Protection Device (EPD). Compatibility with standard guide wires and the seamless integration with interventional procedure workflow promises to set a new standard for the cardiovascular intervention field.
For More Information: www.gardiamedical.comNicole Colomb
(804) 212-2974
ncolomb@vbcc-inc.com - GPB Scientific, LLC
GPB is in the business of selling its proprietary cell separation microchips to life science companies focused on the adult stem cell market. GPB's unique “tools” allow customers to achieve major breakthroughs in separating many more viable stem cells from extracted blood and marrow samples, much quicker and at substantially lower costs than current methods allow.
http://www.gpbscientific.com/
Michael Grisham, managing member
Phone: (804) 225-8809
Fax: (804) 225-8807
Email: mgrisham@gpbscientific.com - Health Diagnostic Laboratory, Inc.
Health Diagnostic Laboratory, Inc. (HDL, Inc.) will be headquartered in Richmond, VA. HDL, Inc. plans to be a fully CAP/CLIA accredited clinical laboratory focused on disease management with supporting clinical laboratory testing for both adult and pediatric patient sectors in the areas of cardiovascular disease (CVD), heart failure, stroke, diabetes mellitus (DM), metabolic syndrome (MS), and nonalcoholic steatohepatitis or fatty liver disease (NASH). HDL, Inc. is founded on the idea that all people and their diseases are not created equally. In order to reverse the alarming increase in chronic diseases, it requires that we examine emerging biomarkers that are more indicative of the mechanics of affected systems. HDL, Inc. provides a unique array of tests that will go far beyond the typical laboratory tests that give physicians a clear understanding of the disease status for each patient so that they are able to make clear decisions of the treatment pathways for each patient. HDL, Inc. offers unique clinical laboratory test results, selected based on their ability to discern the information required to understand each patient's disease state, and will be expanded in response to physicians' requests for continued advanced testing as technology evolves. Our idea is that each treatment plan should be individualized to truly affect positive changes in chronic disease states. This business approach is quite unique in the world of laboratory testing. So much of clinical laboratory testing has become commoditized in the USA. Most laboratories focus on testing volumes and winning bids from private payer health insurance companies in order to continually increase the number of samples tested in their laboratories, especially the large nationals. This type of approach to lab testing is consistent with the managed care approach of the health insurance companies but does not impact on reducing incidence of disease or improving patient outcomes.
804-343-2718 Office
804-343-2704 Fax
www.hdlabinc.com - IBA Molecular
More Info Coming Soon!
- ImmunArray, Ltd.
ImmunArray is developing a groundbreaking in-vitro diagnostic platform system, the I-Chip, which profiles the antibody repertoire in serum, saliva or urine. The first tests will focus on early diagnosis of lung cancer. These profiles will be used for earlier diagnosis of auto-immune diseases, cancer and other immune-related disorders, as well as for selecting the most suitable treatment and for monitoring the response of the individual patient. The company holds exclusive, worldwide license from the Weizmann Institute of Science to develop and to commercialize the Immuno-Chip technology developed by professors Irun Cohen, who is ImmunArray's Chief Science Officer, and Eytan Domany, who serves as a member of ImmunArray's Scientific Advisory Board.
Donna Edmonds
Phone: (804) 212-2975
Fax: (804) 828-8566
Email: dedmonds@vbcc-inc.com - ImmunoTox®, Inc.
Provides in vivo and in vitro immunotoxicological assessment for the pharmaceutical, chemical, medial devices, and food industries.
http://www.immunotox.com/
Kimber L. White, Jr., Ph.D., Founder, President, and CEO
Phone: (804) 828-6880
Fax: (804) 828-6881
Email: kwhite@immunotox.com - Kinakeet Biotechnology
Offers quality protein expression and purification services.
http://www.kinnakeet.com/
Ronald P. Magnusson, Ph.D., President
Email: rmagnus@kinnakeet.com
Michele G. Magnusson, MT (ASCP), COO
Phone: (804) 644-3363
Fax: (804) 506-4414 - Mid-Atlantic Twin Registry
A VCU registry involving more than 32,000 pairs of pre-school, school age and adult twins born in Virginia, North Carolina, and South Carolina.
Judy Silberg, Ph.D. Director, Mid-Atlantic Twin Registry
Phone: (804) 828-8153
Fax: (804) 828-8801
Email: jsilberg@vcu.edu
Lindon Eaves, Ph.D., professor of human genetics Director, VCU Institute for Psychiatric and Behavioral Genetics Co-Director Mid-Atlantic Twin Registry
Phone: (804) 828-8155
Email: eaves@vcu.edu - Molecules for Health, Inc.
Focuses on the research and development of antioxidant drugs for use in treating cancer, AIDS and other diseases.
http://www.moleculesforhealth.com/
Howard Elford, Ph.D., president
Phone: (804) 828-6867
Fax: (804) 828-8566
Email: mol4hlth@vabiotech.com - NeatStitch, Ltd.
NeatStitch LTD, an Israeli based company, has developed a novel medical device, NeatClose, that performs automatic suturing of ports in laparoscopic procedures. This technology is based on a unique Nitinol based platform. The company has a distingusished list of Scientific Advisors ecognized for their leadership in the surgical community.
NeatClose is FDA approved, employs a simple-intuitive blunt end design therefore avoiding exposed needles and improving the safety and speed of the closure for each procedure. The NeatClose system includes a reusable handle which is easily sterilized and a disposable pre packaged cartridge.
For More information please visit: http://www.neatstitch.com/
Nicole Colomb
(804) 212-2974
ncolomb@vbcc-inc.com - New Life Innovations
Designs, develops and markets medical products.
Stanley D. Yeatts, II, M.D., founder
Phone: (757) 867-7281 (Yorktown Office)
Email: syky@verizon.net - NuSil Technology, LLC
Produces a variety of silicone materials for use in biomedical, healthcare and engineering applications.
Jim Lambert, Ph.D., Senior Scientist
Phone: (804) 344-0057
Fax: (804) 344-0057
Email: jiml@nusil.com - Obetech, LLC
Provides research resources and laboratory tests to the scientific community, industry, federal agencies, and the general public for viruses that produce obesity. Services include diagnostic assays in humans and animals for obesity viruses by serum neutralization and polymerase chain reaction (PCR), evaluation of effectiveness of antiviral agents, evaluation of immune enhancement properties of antiviral agents and a variety of molecular biology services including molecular cloning, gene expression analysis, and protein expression and purification.
http://www.obesityvirus.com/
Richard L. Atkinson, President
Phone: (804) 344-5360
Fax: (804)827-8230
Email: ratkinson2@vcu.edu - Orthospace
A spin off of BioProtect Ltd., OrthoSpace has developed a biodegradable balloon that can be implant in the shoulder of patients with massive tears in the muscle and tendon. The implant acts as an artificial bursa, minimizing friction between the bones and the surrounding soft tissue and stops the acute reaction associated with the massive tears.
For more information: http://www.orthospace.co.il/
Kate Webster
(804) 212-2299
kwebster@vbcc-inc.com - Presidium Athletics LLC
Presidium Athletics LLC is focused on the protection of athletes from injury using sophisticated molecular material science and nanotechnology in everyday athletic gear
CONTACT:
Dr. Shawn E. Holt
Chief Scientific Officer
Presidium Athletics LLC
Richmond, VA
seholt@presidium-athletics.com
Cell: 804-514-5839 - Respiratory Drug Delivery and RDD Online, LLC
The organization manages the premier, annual international meeting on pulmonary and nasal drug delivery, and through the provision of peer review articles, books, and on-line education offerings, serves as a central resource for companies and organizations concerned with inhaled product biopharmaceutics, novel aerosol formulations, devices, test methods and related regulatory science. RDD Online also provides up-to-date information, education and recruiting services to corporate customers working on inhaled products.
Peter Byron, Ph.D., president
Phone: (804) 827-1490
Fax: (804) 828-8277
Email: info@rddonline.com
Joanne Peart, Ph.D., Associate Professor Department of Pharmaceutics School of Pharmacy, Virginia Commonwealth University 410 North 12th Street Richmond, VA 23298-0533
Phone: (804) 828 6378
Fax: (804) 828 8359 - SAIC
Conducts medicinal chemistry and structure-based drug design and development research in collaboration with the National Cancer Institute to identify and develop therapeutics to counter biothreat agents.
http://www.saic.com/
Dr. Jim Burnett, Senior Scientist
Phone: (804) 225-0527
Fax: (804) 828-5390
Email: burnettjames@mail.nih.gov - Signal Processing Technologies LLC
Signal Processing Technologies LLC (SPT) is a software development company and invents advanced signal processing, image processing, and machine learning technologies for complex applications in healthcare.
Roya Hakimzadeh, Ph.D.
President and CEO
Signal Processing Technologies
804-385-5913 - Strategic Medical Alliances, Inc. - SMA Informatics
We provide a suite of online secure analytic tools with associated databases that health care executives utilize to gauge their organization's market share, clinical performance and financial efficiency of hospital operations compared with a self-selected peer group
http://www.smainformatics.com/
Warren Brennan, CEO and founder
Phone: (804) 344-8111
Fax: (804) 344-8113
Email: wbrennan@smainformatics.com - SURGICAL OUTCOMES™ Information Exchange (SOIX)
Benchmarking clinical outcomes in ambulatory surgery. The company provides procedure-level benchmarking reports, financial benchmarks, consultative services, employee satisfaction and physician satisfaction services for ambulatory surgery facilities. SOIX also works with leading surgical professional associations to provide continued education services for clinical professionals.
http://www.soix.com/
Lou Rossiter, Ph.D., CEO
Phone: (877) 602-0156
Fax: (804)-740-9401
Email: contact@soix.com - TII Informatix Group
Specializes in the development, operation and management of secure clinical applications, databases and collaborative portals for research, science and business. These systems are designed to help organizations increase operational efficiencies and improve the quality of research data acquisition, analysis and reporting. Our clients and partners include U.S. and international pharmaceutical, life sciences, biotechnology, medical device, academic and government organizations.
- U.S. Commercial Service
Help export-ready, already established small-to-medium sized companies (SMEs) in Virginia export their goods and services to international markets.
W. Eric McDonald, Director
Phone: (804) 771-2246
Fax: (804) 771-2390 - United Network for Organ Sharing (UNOS)
Maintains the national organ transplant waiting list and coordinates the matching and distribution of donated organs to waiting patients. UNOS also is the national repository for organ transplant history and data on all procedures performed in the United States since the organization was formed in Richmond, Va., in 1984.
Walter K. Graham, executive director
Phone: (804) 782-4800
Fax: (804) 782-4817
Email: grahamwk@unos.org - UNOS Foundation
- UNOS Meeting Partners
UNOS Meeting Partners specializes in managing events for organizations within the transplant community.
- VCU Academic Molecular Transplant No description.
- VCU Institute for Psychiatric and Behavioral Genetics
An academic unit of VCU that identifies genes and environments that cause psychiatric diseases and behavioral differences.
Kenneth Kendler, M.D., director
Phone: (804) 828-8800
Email: kendler@hsc.vcu.eduLindon Eaves, Ph.D., director
Phone: (804) 827-0018
Email: eaves@hsc.vcu.edu - VCU Institute for Structural Biology and Drug Discovery
An academic unit of VCU that conducts research and drug development in the areas of structural biology, molecular medicine and biotechnology.
Umesh R. Desai, Ph.D., Interim Director
Phone: (804) 828-7575
Fax: (804)827-3664
Email: urdesai@vcu.edu - VCU Massey Cancer Center Cellular Therapeutics Lab
Located in the Virginia BioTechnology Research Park, the $1.8 million, 5,000 square-foot expanded laboratory includes a large main clinical lab for actual stem cell processing and three smaller GMP laboratories behind a special air lock for advanced cell therapy preparation or therapeutic viral production. In addition, the expansion will provide conference space and office areas to allow researchers to collaborate and to develop clinical protocols.
The Cellular Therapeutics Lab is a physical reflection of the potential of the ongoing partnership of the university, the hospital, and the cancer center in working to solve the cancer problem. This state-of-the-art laboratory is a resource that many institutions and most transplant programs do not have, and will allow VCU, VCUHS, Massey Cancer Center and the Bone Marrow Transplantation Program to retain its place as an institution defining and developing cutting- edge clinical cancer care.
Contact
Patricia Viscardi, MSN, RN
Nurse Manager, Bone Marrow Transplant Program
Office Phone: (804) 628-1164
pviscardi-painter@mcvh-vcu.edu - VCU Office of Vice President for Research
Sponsored Programs, Technology Transfer, Industry Partnerships. Intergrates the central research support functions of the university. Its role is to target strategic research opportunities, serve as a catalyst to bring together research expertise from across the university, provide specialized services to help VCU researchers get external funding and commercialize intellectual property and serve as an information gateway between researchers within the university and those who might access this research expertise outside the university. The offices of Sponsored Programs, Technology Transfer and Industry Partnerships are located in BioTech One.
Susan E. Robb, CRA, Assistant Vice President for Research Administration of Office of Sponsored Programs
Phone: (804) 828-6772
Fax: (804) 828-2521
Email: sarobb@vcu.eduIvelina Metcheva, Ph.D., MBA, Director, Office of Technology Transfer
Phone: (804) 828-5188
Direct line: (804) 827-1213
Fax: (804) 827-0087
Email: ismetche@vcu.edu - VCU School of Pharmacy
The Department of Medicinal Chemistry, an academic unit of the VCU School of Pharmacy, is at the forefront of innovation, blending synthetic chemistry, molecular modeling, computational biology, structural genomics, and pharmacology to discover and design new drugs, and investigate their interaction at the molecular, cellular, and whole-animal level.
Richard A. Glennon, Ph.D., chair
Phone: 804-828-8487
Fax: 804-828-7404
Email: glennon@vcu.edu - VCUHS HLA and Immune Monitoring Lab
The HLA lab is associated with the transplant program at the MCV Hospitals. The lab performs compatibility testing between organ donors and MCVH patients in need of transplants using state-of-the-art molecular genetic testing as well as advanced flow cytometry and luminometry technologies. The lab also participates in clinical trials from various disciplines including transplantation and infectious diseases.
http://www.vcuhealth.org/transplant/
Pamela Kimball, Ph.D., professor of medicine
Phone: (804) 828-9543
Fax: (804) 828-9577
Email: pkimball@gems.vcu.edu - VCUHS Transplant
The Hume Lee Cell Transplant Facility is part of the VCU Medical Center Transplant Department and located in the Virginia BioTechnology Research Park. It oversees a cGMP facility that organizes cell transplants for the VCU Medical Center Transplant Surgical Team, in addition to ongoing research that leads to increasing health care options for liver disease and diabetic patients in our community.
Dr. Robert A. Fisher, MD,
Professor and Director of Adult and Pediatric Liver Transplant Programs and Cell Transplant ProgramDr. Adrian Cotterell, MD,
Assoc. Professor, Scientific Director of Islet Txp ProgramDr. Marc Posner, MD Professor and Chairman, Division of Transplant Surgery, Director Transplant Programs Donna George, Nursing Director & Administrator of Transplant Program
Melissa Thompson Sheehan, Operations Manager of Cell Facility Hume Lee Cell Transplant Facility,
VCU Medical Center
800 E. Leigh Street, Suite 59
Virginia BioTechnology Research Park, 2nd floor
Richmond, VA 23219
Phone: (804) 828-2602 - Virginia Biosciences Commercialization Center
Donna Edmonds
Phone: (804) 212-2973
Fax: (804) 828-8566
Email: dedmonds@vbcc-inc.com - Virginia Biosciences Development Center
David R. Lohr, executive director
Phone: (804) 828-7048
Fax: (804) 827-8230
E-mail: drl@vabiotech.comDeneen Terrell, administrative assistant
Phone: (804) 827-VBDC
Fax: (804) 827-8230
E-mail: vbrp@vabiotech.com - Virginia Biotechnology Association
Represents Virginia's bioscience and device industry with more than 150 members throughout the state.
http://www.vabio.org/
Mark A. Herzog, executive director
Phone: (804) 643-6360
Fax: (804) 643-6361
Email: questions@vabio.org - Virginia Department of Agriculture and Consumer Services
Tests the integrity of seeds sold in Virginia, certifies standard weights and performs plant pathology services. Several VDACS specialty laboratories are housed in BioTech Six.
http://www.vdacs.state.va.us/
Susan Reed, Manager Seed Laboratories
Phone: (804) 786-8795
Email: Susan.Reed@vdacs.virginia.govDale Saunders, Programs Supervisor Metrology Laboratory Phone: (804) 786-2476
Email: Dale.Saunders@vdacs.virginia.gov - Virginia Department of Forensic Science
Applies life-science technologies and other methods and practices to criminal investigation.
http://www.dfs.virginia.gov/
Peter Marone 700 N. 5th Street
Phone: (804) 786-2281
Fax: (804) 786-6857
Email: pete.marone@dfs.virginia.gov - Virginia Division of Consolidated Laboratory Services
Provides analytical testing services to the commonwealth of Virginia and other states as requested through state and federal agencies. Laboratory staff conducts more than 3 million scientific tests each year on air, water, food, gasoline, animal feeds, fertilizers and other substances to help ensure a safe and healthy environment for Virginians and others. DCLS also tests blood samples from all infants born in Virginia as part of the state's newborn screening program. Formed in 1972 when laboratories at several Virginia agencies combined to provide more efficient and cost-effective testing, DCLS was the first consolidated laboratory in the nation to offer a wide variety of scientific testing in support of state programs. Other DCLS services include examination of human specimens for disease control and providing laboratory inspection and certification services as required through the Safe Drinking Water Act and Food and Drug Administration. Testing capabilities have expanded in recent years. DCLS now performs selected testing for the states of West Virginia, North Carolina and New Jersey. In addition to routine testing, DCLS may be called on to respond to various health and environmental emergencies in Virginia.
http://www.dgs.state.va.us/DivisionofConsolidatedLaboratoryServices/tabid/453/Default.aspx
James L. Pearson, Dr. P.H., BCLD, DGS deputy director
Phone: (804) 648-4480, ext. 150
Fax: (804) 371-7973
Email: jpearson@dgs.virginia.govThomas L. York, Ph.D., director Bureau of Analytical Services
Phone: (804) 648-4480, ext. 151
Fax: (804) 371-7973
Email: tyork@dgs.virginia.gov - Virginia Life Science Investments
Paul Rocheleau
Chairman of the Board & Chief Investment Officer
(804) 780-0031
procheleau@vlsillc.comTim Black
Chief Financial Officer
(804) 212-2973
tblack@vbcc-inc.com - Virginia Office of the Chief Medical Examiner
Investigates the deaths of individuals, within the Commonwealth of Virginia, who die a violent death, such as homicide, suicide or accident, as well as people who die under suspicious circumstances, in police custody or unattended by a physician.
http://www.vdh.state.va.us/medexam/
Dr. Leah Bush, chief medical examiner
400 E. Jackson Street
Phone: (804) 786-3174
Fax: (804) 371-8595
Email: Leah.Bush@vdh.virginia.gov - Virginia Tobacco & Health Research Repository, Inc.
The Virginia Tobacco & Health Research Repository, Inc. (VTHRR) was formed to provide access to data and bio-specimens that researchers, institutions, regulators and companies may require in order to investigate the relationships between smoking and tobacco use and human health indications. The core resource of the VTHRR is the Total Exposure Study, one of the largest studies on smoking patterns and tobacco use ever conducted in the United States, consisting of over 5,000 adult males and females, 21 years of age and older who were in generally good health and were enrolled from 39 investigative sites across the U.S. into various parallel investigative groups. Bio-specimens which were collected from study participants consist of urines, plasmas, RBC’s and PBMC’s.
The VTHRR will be filing for non-profit status with the Internal Revenue Service as a 501-c-3 organization and is governed by a 6 member independent Board of Directors representing major public academic research institutions in Virginia, public health laboratories and major non-profit medical centers.
Contact:
Robert T. Skunda, Chairman
Virginia Tobacco & Health Research Repository, Inc.
800 East Leigh Street
Richmond, VA 23219
(804) 828-5390
rts@vabiotech.com - Virtual Ports, Ltd.
Virtual Ports is developing a suite of products in the field of endoscopic surgery. The company provides the mechanism to improve visibility and maneuverability by establishing a series of tools and that can be placed into the working area - the laparoscopic internal field. The mechanism appears to be ideal for natural-orifice translumenal endoscopic surgery, also known as NOTES, an innovative method of abdominal surgery that does not involve an incision in the abdominal wall, as well as other laparoscopic approaches.
Donna Edmonds
Phone: (804) 212-2975
Fax: (804) 828-8566
Email: dedmonds@vbcc-inc.com - Xenolith Medical
Xenolith Medical is developing the new generation of “stone filters” that allow effective blockage of stone debris migration during ureteroscopic procedures, complete removal of trapped debris and considerable simplification of the overall procedure. The company’s approach combines a ureteroscopic guidewire with a “stone filter” which also serves as a retrieval device (or “basket”) into a all-in-one device.
Kate Webster
(804) 212-2299
kwebster@vbcc-inc.com - XVionics
XVionics' core software technology provides multidimensional dependency scheduling, asset management/total asset visibility, intelligent-decision support and risk management in a collaborative environment with the ability to integrate disparate systems. XVionics has a system that has been proven to be successful in the Israeli medical market and is looking to expand into the North American market. The core technology is based on operating software developed for the defense industry in Israel and is in final stage evaluation for inclusion in the U.S. defense industry.
Donna Edmonds
Phone: (804) 827-8231
Fax: (804) 828-8566
Email: dje@vabiotech.com - Zynnovation LLC
Zynnovation LLC is a Virginia-based green technology and biotechnology company established in March 2010. We believe that novel technologies should contribute more to our everyday life and create more opportunities for economic growth. Zynnovation LLC is developing products based on novel green technologies and biomedical technologies. Currently, we focus on research and development of green roof, bio- and chemical sensor, novel green processing technology, medical devices targeting diabetic patients, and pollution prevention and control.
Hailing Yang Ph.D.
President & CEO
Phone: (540) 239-2902
Fax: (804) 302-9100
Email: hailingyang@gmail.com
